Circulating cytokines and angiogenic factors (CAFs) in patients with advanced non-clear cell renal cell carcinoma treated with sunitinib: Results from a phase II clinical trial

被引：0
|
作者：
Bilen, Mehmet Asim [1 ]
Zurita, Amado J. [1 ]
Ilias-Khan, Nasreen A. [1 ]
Chen, Hsiang-Chun [1 ]
Wang, Xuemei [1 ]
Hodges, Sherie [1 ]
Lim, Zita D. [1 ]
Jonasch, Eric [1 ]
Khakoo, Aarif Yusuf [1 ]
Tannir, Nizar M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.483
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial
    Bilen, Mehmet Asim
    Zurita, Amado J.
    Ilias-Khan, Nasreen A.
    Chen, Hsiang-Chun
    Wang, Xuemei
    Kearney, Alper Y.
    Hodges, Sherie
    Jonasch, Eric
    Huang, Shixia
    Khakoo, Aarif Yusuf
    Tannir, Nizar M.
    ONCOLOGIST, 2015, 20 (10): : 1140 - 1148
  • [2] A Phase 2 Trial of Sunitinib in Patients with Advanced Non-clear Cell Renal Cell Carcinoma
    Tannir, Nizar M.
    Plimack, Elizabeth
    Chaan Ng
    Tamboli, Pheroze
    Bekele, Nebiyou B.
    Xiao, Lianchun
    Smith, Lisa
    Lim, Zita
    Pagliaro, Lance
    Araujo, John
    Aparicio, Ana
    Matin, Surena
    Wood, Christopher G.
    Jonasch, Eric
    EUROPEAN UROLOGY, 2012, 62 (06) : 1013 - 1019
  • [3] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Molina, Ana M.
    Feldman, Darren R.
    Ginsberg, Michelle S.
    Kroog, Glenn
    Tickoo, Satish K.
    Jia, Xiaoyu
    Georges, Murielle
    Patil, Sujata
    Baum, Michael S.
    Reuter, Victor E.
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 335 - 340
  • [4] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Ana M. Molina
    Darren R. Feldman
    Michelle S. Ginsberg
    Glenn Kroog
    Satish K. Tickoo
    Xiaoyu Jia
    Murielle Georges
    Sujata Patil
    Michael S. Baum
    Victor E. Reuter
    Robert J. Motzer
    Investigational New Drugs, 2012, 30 : 335 - 340
  • [5] Prognostic and predictive plasma cytokines and angiogenic factors (CAF) in patients (pts) with advanced non-clear cell renal cell carcinoma treated with first-line sunitinib or everolimus: Results from the ESPN trial.
    Msaouel, Pavlos
    Zurita, Amado J.
    Huang, Shixia
    Jonasch, Eric
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
    Lee, J. -L.
    Ahn, J. -H.
    Lim, H. Y.
    Park, S. H.
    Lee, S. H.
    Kim, T. M.
    Lee, D. -H.
    Cho, Y. M.
    Song, C.
    Hong, J. H.
    Kim, C. -S.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 2108 - 2114
  • [7] Re: A Phase 2 Trial of Sunitinib in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2012, 188 (06): : 2146 - 2147
  • [8] ASPEN: A randomized phase II trial of everolimus versus sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Armstrong, Andrew J.
    Halabi, Susan
    Eisen, Tim
    Stadler, Walter Michael
    Jones, Robert R.
    Vaishampayan, Ultra N.
    Garcia, Jorge A.
    Hawkins, Robert E.
    Kollmannsberger, Christian K.
    Lusk, Christine
    Broderick, Samuel
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Safety and efficacy of sunitinib for advanced non-clear cell renal cell carcinoma
    Shi, Hong-Zhe
    Tian, Jun
    Li, Chang-Ling
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (04) : 328 - 333
  • [10] Final clinical results of a randomized phase II international trial of everolimus vs. sunitinib in patients with metastatic non-clear cell renal cell carcinoma (ASPEN)
    Armstrong, Andrew J.
    Broderick, Samuel
    Eisen, Tim
    Stadler, Walter Michael
    Jones, Robert J.
    Garcia, Jorge A.
    Vaishampayan, Ulka N.
    Picus, Joel
    Hawkins, Robert E.
    Hainsworth, John D.
    Kollmannsberger, Christian K.
    Logan, Theodore F.
    Puzanov, Igor
    Pickering, Lisa M.
    Ryan, Christopher W.
    Protheroe, Andrew
    Lusk, Christine M.
    Oberg, Sadie
    Halabi, Susan
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345